Many /most will be on generic Lipitor and maybe some on Crestor in R-IT ....
Of course more patients are on Liptor or Crestor than in JELIS and yes LDL is app. 50% lower (max. 100), but you overestimate the share of these. I posted a market share to you earlier and ANCHOR was: - simvastatin: 57.4% - rosuvastatin: 23.8% - atorvastatin: 18.8%